Pharmafile Logo
Pharmafocus logo
Advanced Search
Roche picture

Roche launches $5.7 billion hostile bid for Illumina

January 25, 2012
Research and Development, Sales and Marketing Diagnostics, Illumina, Roche

Roche has launched a hostile takeover bid for US diagnostics company Illumina. The Swiss manufacturer appears tired of waiting for …

News

Premier Research appoints Etienne Drouet as executive director, Oncology Europe

January 25, 2012
Business Services, Research and Development, Sales and Marketing Etienne Drouet, Premier Research

 Premier Research Group has announced the appointment of Etienne Drouet to the position of executive director, Oncology Europe.In this position, …

Appointment

Gates urges investment in innovations for developing nations

January 25, 2012
Research and Development AIDS, Bill Gates, Global Fund, TB, malaria

Bill Gates has called on global leaders to invest in innovations that are accelerating progress against poverty, or risk a …

News
Lansley picture

Councils given £2.2 billion for public health

January 25, 2012
Research and Development, Sales and Marketing Lansley, NHS, public health outcomes framework

The government’s new vision for public health has come under fire from observers worried that accountability for the strategy remains …

News

MHRA Inspections of CROs

January 24, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Audits, Wainwright Associates, inspectons

In accordance with the provisions of the new pharmacovigilance legislation, as per Directive 2010/84/EU, EU Competent Authorities may inspect the …

News
Press release

Moving towards milestones: the evolving pharma – biotech relationship

January 24, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Deals, Susan Aldridge, biotech, pharma

Big pharma is going through the greatest ever wave of patent expiries, while small biotechs are finding it hard to …

Feature

Richard Barker elected to Celgene’s board of directors

January 24, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing ABPI, Celgene, Richard Barker

Celgene, the biopharma firm specialising in cancer and inflammatory diseases, has elected Richard Barker to its board of directors. Dr …

Appointment
Genzyme picture

Genzyme’s Framingham site cleared by FDA

January 24, 2012
Manufacturing and Production FDA, Fabrazyme, Fabry, Genzyme

The FDA has cleared Genzyme to begin production of Fabrazyme at its new manufacturing site. The approval of the new …

News

Patheon gets bigger in softgels with Procaps alliance

January 24, 2012
Manufacturing and Production Patheon, Procaps, manufacturing

Contract development and manufacturing organisation Patheon has stepped up its position in the market for pharmaceutical capsules with the signing …

News

Alnylam cuts workforce by a third

January 23, 2012
Research and Development, Sales and Marketing Alnylam, Novartis, job cuts, rnai

Alnylam will cut 33% of its workforce this year as it looks to focus on developing its own products. The …

News

MPs to criticise NHS reforms

January 23, 2012
Sales and Marketing Clegg, Dorrell, NHS reform, health bill

Reform of the NHS is risking its financial stability and the care of the elderly, according to MPs. The concerns …

News

Carbogen Amcis buys French CRO

January 23, 2012
Manufacturing and Production Carbogen Amcis, Creapharm Parenterals

Swiss contract manufacturing organisation Carbogen Amcis has acquired a contract manufacturer based in France – Creapharm Parenterals – to bolster …

News

Contract research news in brief

January 23, 2012
Research and Development CoreLab Partners and Acurian, Quintiles, vivoPharma

Quintiles invests in new biomarket firm and sets up a new office in China, plus updates from vivoPharma, CoreLab Partners …

News
Vioxx image

Merck pays $37m to settle Canadian Vioxx claims

January 23, 2012
Sales and Marketing Canada, Merck, Vioxx

Merck will pay a maximum of C$37 million to settle all claims against its painkiller Vioxx in Canada.  The settlement …

News

Genzyme lifted by EU approval of Fabrazyme facility

January 20, 2012
Manufacturing and Production Boston, EMA, Fabrazyme, Genzyme

Sanofi subsidiary Genzyme moved a crucial step closer to resolving its long-standing manufacturing problems after the European Medicines Agency gave …

News

Payment changes of authority’s fees in France

January 20, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates, regulatory affairs

Changes are being made in the way fees are paid for regulatory submissions and procedures in France.  Fees are no …

News
Press release

Novartis’ Signifor recommended in Europe

January 20, 2012
Research and Development, Sales and Marketing CHMP, Cushing's disease, Novartis, Signifor

A European committee has recommended Novartis’ Signifor for the treatment of a rare, debilitating endocrine disorder. The European Committee for …

News
Gilenya image

EMA to review safety of MS drug Gilenya

January 20, 2012
Research and Development, Sales and Marketing CHMP, EMA, Novartis, gilenya

The European Medicines Agency has begun a review into the safety of Novartis’ multiple sclerosis drug Gilenya. This follows concerns …

News

British pharmacy to sell ‘smart pills’

January 20, 2012
Sales and Marketing Lloyds pharmacy, Proteus Biomedical, smart pill

Proteus Biomedical has teamed up with Lloydspharmacy to sell Helius, a smart pill that tells a patient when to take …

News

AZ and BMS diabetes drug needs more data

January 20, 2012
Research and Development, Sales and Marketing AstraZeneca, BMS, FDA approvals, diabetes

AstraZeneca and Bristol-Myers Squibb must supply more data on their diabetes treatment dapagliflozin, the FDA says.Currently being developed as monotherapy, …

News
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026